跳至主要内容
临床试验/ISRCTN18388825
ISRCTN18388825进行中(未招募)未知

Barriers and facilitators to deprescribing antithrombotic therapy in advanced cancer patients: A qualitative interview study of patients’, companions’ and clinicians’ experiences and perspectives

Cardiff University0 个研究点目标入组 39 人开始时间: 2023年2月8日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
39

研究概览

简要总结

暂无简介。

研究设计

研究类型
Other

入排标准

性别
All

入选标准

  • 1. Aged 18 years old and over
  • 2. Advanced cancer (whose life expectancy is less than one year, according to the healthcare professional identifying eligible participants)
  • 3. Receiving antithrombotic medicine for one of the following diseases: atrial fibrillation/stroke prevention, mechanical heart valve, peripheral vascular disease, and deep vein thrombosis or pulmonary embolus
  • 4. Capacity to give informed consent
  • 5. Capacity to undertake an interview in English
  • Companions:
  • 1. Companions are defined as person(s) who look after and/or support the patient as identified and chosen by the patient to take part alongside them, should the companion wish to do so
  • 2. Aged 18 years old and over
  • 3. Capacity to give informed consent
  • 4. Capacity to undertake an interview in English
  • Clinicians:
  • Clinicians practising in their chosen speciality for 10 years or more, from across the following specialities: oncology, care of the elderly, frailty, stroke medicine, palliative/hospice care, family physician/general practice, cardiology, respiratory medicine, and vascular surgery

排除标准

  • Patients and companions:
  • 1. Cognitive impairment
  • 2. Unable to speak or understand English
  • 3. Considered too unwell to participate in a 30-60 minute interview

研究者

相似试验